Sapporo Clinical Laboratory (TSE:9776) EV-to-EBITDA : 2.37 (As of Jun. 22, 2024)

Sapporo Clinical Laboratory EV-to-EBITDA Chart

Sapporo Clinical Laboratory Annual Data
	Trend	Mar14	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23
EV-to-EBITDA		Get a 7-Day Free Trial					2.04	2.59	3.44	2.02	2.21

Sapporo Clinical Laboratory Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															1.80	2.21	3.17	2.21	3.18

Competitive Comparison of Sapporo Clinical Laboratory's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, Sapporo Clinical Laboratory's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sapporo Clinical Laboratory's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sapporo Clinical Laboratory's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sapporo Clinical Laboratory's EV-to-EBITDA falls into.

Sapporo Clinical Laboratory EV-to-EBITDA Calculation

Sapporo Clinical Laboratory's EV-to-EBITDA for today is calculated as:

Sapporo Clinical Laboratory's current Enterprise Value is 円1,388 Mil.
Sapporo Clinical Laboratory's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円585 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sapporo Clinical Laboratory  (TSE:9776) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sapporo Clinical Laboratory's PE Ratio for today is calculated as:

Sapporo Clinical Laboratory's share price for today is 円1000.00.
Sapporo Clinical Laboratory's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円116.312.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Sapporo Clinical Laboratory EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sapporo Clinical Laboratory's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Sapporo Clinical Laboratory (TSE:9776) Business Description